Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
Authors:
- 1 May 2011
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 70 (5) , 812-817
Abstract
Objectives To compare markers of cardiovascular disease (CVD) risk between patients with rheumatoid arthritis (RA) in an active disease state and those with RA in remission, and to compare both groups with community controls. Methods 113 patients with RA and 86 community controls were assessed across a panel of biomarkers for CVD. RA in remission was defined as Clinical Disease Activity Index ≤2.8. Community controls were selected at random by Statistics Norway, and controls were matched with patients in the cohorts in strata using details of age, sex and residential area. A panel of biomarkers (N-terminal pro-brain natriuretic peptide (NT-proBNP), total cholesterol, reactive hyperaemia index (RHI), pressure measurements, measures of arterial stiffness and intima-media thickness) were compared between patients with active RA and those with RA in remission. Both groups were compared with controls. In addition, biomarker levels were compared across subgroups based on anticyclic citrullinated peptide status, level of joint destruction and presence of extra-articular manifestations. Results Patients with active RA had significantly higher levels of NT-proBNP, brachial systolic pressure, augmentation index and central systolic pressure but lower cholesterol than patients in remission and controls. In addition, patients with active RA had significantly higher levels of pulse wave velocity and worse RHI than patients in remission. Comparison across other subgroups gave less consistent differentiations in levels of CVD risk markers. Conclusion Patients with active RA, but not those in remission, had significantly increased levels of CVD risk markers. These results link inflammatory activity to markers of CVD risk in patients with RA and may indirectly support the notion that remission in RA confers diminished cardiovascular morbidity.Keywords
This publication has 46 references indexed in Scilit:
- High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular OutcomeJACC, 2009
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta‐analysis of observational studiesArthritis Care & Research, 2008
- Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population‐based cohort studyArthritis & Rheumatism, 2005
- Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemiaJACC, 2004
- Cardiovascular risk factors in women with and without rheumatoid arthritisArthritis & Rheumatism, 2004
- High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsArthritis & Rheumatism, 2001
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Serum Lipoprotein in Active Rheumatoid Arthritis and Other Chronic Inflammatory ArthritidesArchives of internal medicine (1960), 1987
- The arthritis impact measurement scales. further investigations of a health status measureArthritis & Rheumatism, 1982
- Dyslipoproteinaemia in patients with active, chronic polyarthritis. a study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test)Atherosclerosis, 1977